China Medicine Price to Sales Ratio 2010-2010 | CHME
Historical PS ratio values for China Medicine (CHME) over the last 10 years. The current P/S ratio for China Medicine as of June 26, 2025 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| China Medicine P/S Ratio Historical Data |
| Date |
Stock Price |
TTM Sales per Share |
Price to Sales Ratio |
| 2025-06-25 |
0.00 |
|
0.00 |
| 2010-09-30 |
2.06 |
$2.71 |
0.76 |
| 2010-06-30 |
2.42 |
$3.51 |
0.69 |
| 2010-03-31 |
3.44 |
$4.06 |
0.85 |
| 2009-12-31 |
4.30 |
$4.16 |
1.03 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.000B |
$0.000B |
|
China Medicine Corporation is a distributor of pharmaceutical and medical products, including prescription and over-the-counter drugs, Chinese herbs, traditional Chinese medicines made from Chinese herbs, nutritional supplements, dietary supplements, and medical instruments. The company is also engaged in proprietary research and development with the aim of creating new pharmaceutical products and intellectual property that it may sell in the future. China Medicine Corporation also sells improved drug formulas after purchasing the rights to drug formulas at an early stage of development and improving those formulas through its own research. The company's mission is to become a leading research-driven pharmaceutical company in China dedicated to the discovery, development, distribution and manufacturing of pharmaceutical products and nutritional supplements.
|
